Summary
CVS Health Corporation reported total revenues of $88.4 billion for the first quarter of 2024, a 3.7% increase compared to the prior year, primarily driven by growth in its Health Care Benefits and Pharmacy & Consumer Wellness segments. However, net income attributable to CVS Health significantly decreased by 47.9% to $1.113 billion ($0.88 diluted EPS) from $2.136 billion ($1.65 diluted EPS) in the first quarter of 2023. This decline was largely attributed to increased Medicare utilization, unfavorable impacts from lower Medicare Advantage star ratings, and higher health care costs in the Health Care Benefits segment, as well as challenges in the Health Services segment including client price improvements and the loss of a large client. The company's operational performance reflects a mixed picture, with revenue growth being overshadowed by a substantial drop in profitability. While the Health Care Benefits segment saw strong revenue growth from Medicare and Commercial product lines, its Medical Benefit Ratio (MBR) increased significantly due to higher utilization. The Health Services segment experienced a revenue decline primarily due to client losses and pricing pressures, despite contributions from recent acquisitions. The Pharmacy & Consumer Wellness segment demonstrated solid revenue growth driven by increased prescription volume and favorable drug mix, alongside a slight increase in adjusted operating income. CVS Health's balance sheet remains robust with total assets of $249.7 billion. The company also continued its share repurchase program, repurchasing $3.0 billion of common stock in the quarter. Despite the profitability dip, the company's outlook suggests expected growth from new ventures like Cordavis, Oak Street Health, and Signify Health, though it anticipates continued pressure on its Health Care Benefits segment due to sustained high Medicare utilization.
Financial Highlights
55 data points| Revenue | $88.44B |
| Cost of Revenue | $48.07B |
| Gross Profit | $40.36B |
| Operating Expenses | $86.17B |
| Operating Income | $2.27B |
| Interest Expense | $716.00M |
| Net Income | $1.11B |
| EPS (Basic) | $0.88 |
| EPS (Diluted) | $0.88 |
| Shares Outstanding (Basic) | 1.26B |
| Shares Outstanding (Diluted) | 1.27B |
Key Highlights
- 1Total revenues increased by 3.7% to $88.4 billion in Q1 2024, driven by Health Care Benefits and Pharmacy & Consumer Wellness segments.
- 2Net income attributable to CVS Health decreased significantly by 47.9% to $1.113 billion, with diluted EPS falling to $0.88 from $1.65 year-over-year.
- 3The Health Care Benefits segment experienced a substantial 69.6% drop in operating income, primarily due to increased Medicare utilization and lower Medicare Advantage star ratings, leading to a higher Medical Benefit Ratio (MBR) of 90.4%.
- 4The Health Services segment saw a 9.7% decline in total revenues due to client loss and pricing pressures, resulting in a 18.9% decrease in adjusted operating income.
- 5The Pharmacy & Consumer Wellness segment reported a 2.9% increase in total revenues and a 3.8% rise in adjusted operating income, supported by higher prescription volumes and favorable drug mix.
- 6CVS Health repurchased $3.0 billion of its common stock in the first quarter of 2024.
- 7The company anticipates continued pressure on its Health Care Benefits segment due to persistent high Medicare utilization in the near term.